Shanghai Haoyuan Chemexpress Co (SHSE:688131) Piotroski F-Score: 5 (As of Sep. 09, 2026) — 25% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688131 Shanghai Haoyuan Chemexpress Co Ltd SHSE:688131
90 GF Score
Price ¥93.74
GF Value ¥68.96
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is Shanghai Haoyuan Chemexpress Co Piotroski F-Score?

Shanghai Haoyuan Chemexpress Co SHSE:688131 -0.98% 90 Piotroski F-Score is 5 as of Sep. 09, 2026, which is 25% above its 10-year median of 4.00. GuruFocus rates SHSE:688131 with a GF Score™ of 90/100 and a GF Value™ of ¥68.96 (Significantly Overvalued). The stock has 10 warning signs investors should review. Among 985 Drug Manufacturers companies, Shanghai Haoyuan Chemexpress Co ranks better than 61.42% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Shanghai Haoyuan Chemexpress Co has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Shanghai Haoyuan Chemexpress Co's Piotroski F-Score or its related term are showing as below:

SHSE:688131' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 4   Max: 8
Current: 5

During the past 13 years, the highest Piotroski F-Score of Shanghai Haoyuan Chemexpress Co was 8. The lowest was 1. And the median was 4.

Shanghai Haoyuan Chemexpress Co  (SHSE:688131) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Shanghai Haoyuan Chemexpress Co Piotroski F-Score Related Terms


Shanghai Haoyuan Chemexpress Co Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Shanghai Haoyuan Chemexpress Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Haoyuan Chemexpress Co Piotroski F-Score Chart

Shanghai Haoyuan Chemexpress Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 1.00 3.00 7.00 4.00

Shanghai Haoyuan Chemexpress Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.00 7.00 4.00 4.00 5.00

SHSE:688131 vs ZTS: Piotroski F-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Haoyuan Chemexpress Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Haoyuan Chemexpress Co Piotroski F-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Haoyuan Chemexpress Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Shanghai Haoyuan Chemexpress Co's Piotroski F-Score falls into.


SHSE:688131
90GF Score
Shanghai Haoyuan Chemexpress Co Ltd SHSE:688131
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun26) TTM:Last Year (Jun25) TTM:
Net Income was 84.897 + 3.148 + 67.841 + 103.36 = ¥259 Mil.
Cash Flow from Operations was 105.01 + 223.17 + 36.571 + 40.493 = ¥405 Mil.
Revenue was 748.123 + 817.83 + 728.651 + 919.323 = ¥3,214 Mil.
Gross Profit was 380.992 + 330.86 + 381.996 + 454.578 = ¥1,548 Mil.
Average Total Assets from the begining of this year (Jun25)
to the end of this year (Jun26) was
(5842.546 + 6070.436 + 6294.274 + 6489.539 + 6699.049) / 5 = ¥6279.1688 Mil.
Total Assets at the begining of this year (Jun25) was ¥5,843 Mil.
Long-Term Debt & Capital Lease Obligation was ¥1,263 Mil.
Total Current Assets was ¥4,179 Mil.
Total Current Liabilities was ¥2,011 Mil.
Net Income was 72.94 + 58.242 + 62.384 + 89.377 = ¥283 Mil.

Revenue was 563.514 + 651.114 + 606.125 + 704.818 = ¥2,526 Mil.
Gross Profit was 291.417 + 318.528 + 294.477 + 348.791 = ¥1,253 Mil.
Average Total Assets from the begining of last year (Jun24)
to the end of last year (Jun25) was
(4372.65 + 4683.503 + 5504.946 + 5713.529 + 5842.546) / 5 = ¥5223.4348 Mil.
Total Assets at the begining of last year (Jun24) was ¥4,373 Mil.
Long-Term Debt & Capital Lease Obligation was ¥1,267 Mil.
Total Current Assets was ¥3,509 Mil.
Total Current Liabilities was ¥1,447 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Shanghai Haoyuan Chemexpress Co's current Net Income (TTM) was 259. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Shanghai Haoyuan Chemexpress Co's current Cash Flow from Operations (TTM) was 405. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun25)
=259.246/5842.546
=0.04437209

ROA (Last Year)=Net Income/Total Assets (Jun24)
=282.943/4372.65
=0.06470744

Shanghai Haoyuan Chemexpress Co's return on assets of this year was 0.04437209. Shanghai Haoyuan Chemexpress Co's return on assets of last year was 0.06470744. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Shanghai Haoyuan Chemexpress Co's current Net Income (TTM) was 259. Shanghai Haoyuan Chemexpress Co's current Cash Flow from Operations (TTM) was 405. ==> 405 > 259 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun25 to Jun26
=1262.63/6279.1688
=0.20108235

Gearing (Last Year: Jun25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun24 to Jun25
=1266.989/5223.4348
=0.24255859

Shanghai Haoyuan Chemexpress Co's gearing of this year was 0.20108235. Shanghai Haoyuan Chemexpress Co's gearing of last year was 0.24255859. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun26)=Total Current Assets/Total Current Liabilities
=4178.7/2010.844
=2.07808264

Current Ratio (Last Year: Jun25)=Total Current Assets/Total Current Liabilities
=3509.469/1446.645
=2.42593656

Shanghai Haoyuan Chemexpress Co's current ratio of this year was 2.07808264. Shanghai Haoyuan Chemexpress Co's current ratio of last year was 2.42593656. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Shanghai Haoyuan Chemexpress Co's number of shares in issue this year was 210.715. Shanghai Haoyuan Chemexpress Co's number of shares in issue last year was 213.612. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1548.426/3213.927
=0.4817863

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=1253.213/2525.571
=0.49620977

Shanghai Haoyuan Chemexpress Co's gross margin of this year was 0.4817863. Shanghai Haoyuan Chemexpress Co's gross margin of last year was 0.49620977. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun25)
=3213.927/5842.546
=0.55009015

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun24)
=2525.571/4372.65
=0.57758362

Shanghai Haoyuan Chemexpress Co's asset turnover of this year was 0.55009015. Shanghai Haoyuan Chemexpress Co's asset turnover of last year was 0.57758362. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+0+1+0+0
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Shanghai Haoyuan Chemexpress Co has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
Shanghai Haoyuan Chemexpress Co (SHSE:688131) has a Piotroski F-Score of 5 as of Sep. 09, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Shanghai Haoyuan Chemexpress Co and its competitors. This is 25% above median its historical median of 4.00. Over the past decade, Shanghai Haoyuan Chemexpress Co's Piotroski F-Score has ranged from 1.00 to 8.00. According to the industry distribution chart, Shanghai Haoyuan Chemexpress Co ranks #380 out of 985 companies in the Drug Manufacturers industry, placing it in the top 38.6%.
Is Shanghai Haoyuan Chemexpress Co's Piotroski F-Score too high?
Shanghai Haoyuan Chemexpress Co's current Piotroski F-Score of 5 is 25% above median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 8.00. The Drug Manufacturers industry median Piotroski F-Score is 5.00. Shanghai Haoyuan Chemexpress Co's value of 5 is 0% at this industry median. Based on the distribution chart, Shanghai Haoyuan Chemexpress Co ranks #380 out of 985 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Shanghai Haoyuan Chemexpress Co has a GF Score™ of 90/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Haoyuan Chemexpress Co's Piotroski F-Score compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Shanghai Haoyuan Chemexpress Co ranks #380 out of 985 companies for Piotroski F-Score. This puts Shanghai Haoyuan Chemexpress Co in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Shanghai Haoyuan Chemexpress Co's value of 5 is 0% at this benchmark. Historically, Shanghai Haoyuan Chemexpress Co's own Piotroski F-Score has ranged from 1.00 to 8.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, Shanghai Haoyuan Chemexpress Co has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Drug Manufacturers company?
The median Piotroski F-Score among Drug Manufacturers companies is 5.00, based on 985 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Haoyuan Chemexpress Co's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Shanghai Haoyuan Chemexpress Co and its competitors. For the Drug Manufacturers industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Haoyuan Chemexpress Co's current Piotroski F-Score is 5, which is 25% above median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Haoyuan Chemexpress Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Haoyuan Chemexpress Co (SHSE:688131) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥68.96, compared to a current price of ¥93.74 — trading 35.9% above its estimated fair value. The current Piotroski F-Score is 5, which is 25% above median its 10-year median of 4.00 and 0% at the Drug Manufacturers industry median of 5.00. Shanghai Haoyuan Chemexpress Co's overall GF Score™ is 90/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Shanghai Haoyuan Chemexpress Co (SHSE:688131), the current Piotroski F-Score is 5 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Haoyuan Chemexpress Co (SHSE:688131) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Haoyuan Chemexpress Co stock appears to be overvalued. The current stock price of ¥93.74 is trading 35.9% above its estimated GF Value™ of ¥68.96. GuruFocus considers Shanghai Haoyuan Chemexpress Co to be Significantly Overvalued.

Key valuation signals for SHSE:688131:

  • Piotroski F-Score: 5 (25% above median its 10-year median of 4.00)
  • GF Value™: ¥68.96 vs. price of ¥93.74 (35.9% above fair value)
  • GF Score™: 90/100 with 10 warning signs
  • Industry Position: 0% at the Drug Manufacturers median (#380 of 985)

No single metric tells the full story. See the SHSE:688131 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Haoyuan Chemexpress Co Business Description

Address No. 2, Lane 720, Cailun Road, Room 501, Pilot Free Trade Zone, Shanghai, CHN, 201203
Shanghai Haoyuan Chemexpress Co Ltd focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. The company's comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. It is a one-stop service platform to support client's projects from early drug discovery, process development to commercialization. The company is committed to delivering high-quality products and CMC services to clients across the entire life cycle of drug development.
90GF Score

Get the complete analysis for SHSE:688131

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥93.74
Price
¥68.96
GF Value